Melanoma and Skin Cancer Trials Limited   Report issue

For profit Phase 2
Founded: Victoria Australia (1999)

Organization Overview

First Clinical Trial
2020
NCT04261855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Melanoma and Skin Cancer Trials Limited